← MOLINA HEALTHCARE, INC. MOH
Market Price
$212.57
Market Cap
$10.71B
P/E Ratio
23.83
Revenue (FY 2025)
↑11.7% YoY
$45.43B
3-Yr CAGR: 12.4%
Net Income
↓-60.0% YoY
$472.00M
Net Margin: 1.0%
Free Cash Flow
↓-216.9% YoY
-$636.00M
FCF Yield: -5.94%
EPS (Diluted)
↓-56.3% YoY
$8.92
Basic: $8.93
Return on Equity
Efficiency
11.6%
ROA: 3.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MOH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $17,782.0M | — | $1,672.0M | $52.0M | — | $0.92 | — | $673.0M | $497.0M | — |
| FY 2017 | $19,883.0M | +11.8% | $1,810.0M | $-512.0M | -1,084.6% | $-9.07 | -1,085.9% | $804.0M | $718.0M | +44.5% |
| FY 2018 | $407.0M | -98.0% | $2,518.0M | $707.0M | +238.1% | $10.61 | +217.0% | $-314.0M | $-344.0M | -147.9% |
| FY 2019 | — | -100.0% | $2,303.0M | $737.0M | +4.2% | $11.47 | +8.1% | $427.0M | $370.0M | +207.6% |
| FY 2020 | $19,423.0M | — | $2,479.0M | $673.0M | -8.7% | $11.23 | -2.1% | $1,890.0M | $1,816.0M | +390.8% |
| FY 2021 | $27,771.0M | +43.0% | $4,067.0M | $659.0M | -2.1% | $11.25 | +0.2% | $2,119.0M | $2,042.0M | +12.4% |
| FY 2022 | $31,974.0M | +15.1% | $4,799.0M | $792.0M | +20.2% | $13.55 | +20.4% | $773.0M | $682.0M | -66.6% |
| FY 2023 | $34,072.0M | +6.6% | $5,403.0M | $1,091.0M | +37.8% | $18.77 | +38.5% | $1,662.0M | $1,578.0M | +131.4% |
| FY 2024 | $40,650.0M | +19.3% | $6,222.0M | $1,179.0M | +8.1% | $20.42 | +8.8% | $644.0M | $544.0M | -65.5% |
| FY 2025 | $45,426.0M | +11.7% | $5,938.0M | $472.0M | -60.0% | $8.92 | -56.3% | $-535.0M | $-636.0M | -216.9% |
Valuation
Market Price
$212.57
Market Cap
$10.71B
Enterprise Value
$10.23B
P/E Ratio
23.83
P/B Ratio
2.72
FCF Yield
-5.94%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
13.07%
Operating Margin
1.72%
Net Margin
1.04%
Return on Equity (ROE)
11.60%
Return on Assets (ROA)
3.03%
Asset Turnover
2.92x
Revenue 3-Yr CAGR
12.42%
Financial Health & Liquidity
Current Ratio
0.09
Cash Ratio
0.58
Debt / Equity
0.926
Debt / Assets
0.242
Cash & Equivalents
$4.25B
Total Debt
$3.77B
Book Value / Share
$78.10
Cash Flow Efficiency
Operating Cash Flow
-$535.00M
Capital Expenditures (CapEx)
$101.00M
Free Cash Flow
-$636.00M
OCF / Revenue
-1.18%
FCF / Revenue
-1.40%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$8.92
EPS (Basic)
$8.93
Dividends / Share
N/A
Book Value / Share
$78.10
EPS YoY Growth
-56.32%
Balance Sheet (FY 2025)
Total Assets
$15.56B
Total Liabilities
$15.56B
Stockholders' Equity
$4.07B
Current Assets
$655.00M
Current Liabilities
$7.37B